Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Medicare Part D coverage gap and diabetes beneficiaries.

Schmittdiel JA, Ettner SL, Fung V, Huang J, Turk N, Quiter ES, Swain BE, Hsu JT, Mangione CM.

Am J Manag Care. 2009 Mar;15(3):189-93.

2.

Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.

Fung V, Mangione CM, Huang J, Turk N, Quiter ES, Schmittdiel JA, Hsu J.

Health Serv Res. 2010 Apr;45(2):355-75. doi: 10.1111/j.1475-6773.2009.01071.x. Epub 2009 Dec 30.

3.

Beneficiaries with cardiovascular disease and thePart D coverage gap.

Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Roebuck MC, Schneeweiss S.

Circ Cardiovasc Qual Outcomes. 2012 May;5(3):387-95. doi: 10.1161/CIRCOUTCOMES.111.964866. Epub 2012 Apr 17.

4.

Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.

Conwell LJ, Esposito D, Garavaglia S, Meadows ES, Colby M, Herrera V, Goldfarb S, Ball D, Marciniak M.

Am J Geriatr Pharmacother. 2011 Aug;9(4):241-9. doi: 10.1016/j.amjopharm.2011.04.009. Epub 2011 May 26.

PMID:
21616722
5.

Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.

Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC.

J Manag Care Spec Pharm. 2014 Aug;20(8):862-76.

6.

Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.

Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM.

JAMA. 2004 Aug 25;292(8):952-60.

PMID:
15328327
7.

Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.

Yala SM, Duru OK, Ettner SL, Turk N, Mangione CM, Brown AF.

BMC Health Serv Res. 2014 Dec 20;14:665. doi: 10.1186/s12913-014-0665-3.

8.

Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.

Hsu J, Fung V, Price M, Huang J, Brand R, Hui R, Fireman B, Newhouse JP.

JAMA. 2008 Apr 23;299(16):1929-36. doi: 10.1001/jama.299.16.1929.

PMID:
18430912
9.

Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.

Nair KV, Frech-Tamas F, Jan S, Wolfe P, Allen RR, Saseen JJ.

J Health Care Finance. 2011 Winter;38(2):38-53.

PMID:
22372031
10.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
11.

Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.

Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC.

J Manag Care Spec Pharm. 2015 Oct;21(10):956-64.

12.

Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts.

Elliott MN, Landon BE, Zaslavsky AM, Edwards C, Orr N, Beckett MK, Mallett J, Cleary PD.

Health Aff (Millwood). 2016 Mar;35(3):456-63. doi: 10.1377/hlthaff.2015.0816.

PMID:
26953300
13.

Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.

Blumberg DM, Prager AJ, Liebmann JM.

JAMA Ophthalmol. 2016 Feb;134(2):212-20. doi: 10.1001/jamaophthalmol.2015.5090.

PMID:
26720853
14.

The Medicare Part D doughnut hole: effect on pharmacy utilization.

Sun SX, Lee KY.

Manag Care Interface. 2007 Sep;20(9):51-5, 59.

PMID:
18161394
15.

Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.

Patel RA, Walberg MP, Tong E, Tan F, Rummel AE, Woelfel JA, Carr-Lopez SM, Galal SM.

J Manag Care Spec Pharm. 2014 Mar;20(3):283-90.

16.
17.

Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.

Duru OK, Mangione CM, Hsu J, Steers WN, Quiter E, Turk N, Ettner SL, Schmittdiel JA, Tseng CW.

J Am Geriatr Soc. 2010 May;58(5):822-8. doi: 10.1111/j.1532-5415.2010.02813.x. Epub 2010 Apr 6.

18.

Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: a TRIAD Study.

Schmittdiel JA, Steers N, Duru OK, Ettner SL, Brown AF, Fung V, Hsu J, Quiter E, Tseng CW, Mangione CM.

BMC Health Serv Res. 2010 Jun 14;10:164. doi: 10.1186/1472-6963-10-164.

19.

Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?

Mott DA, Thorpe JM, Thorpe CT, Kreling DH, Gadkari AS.

Res Social Adm Pharm. 2010 Jun;6(2):90-9. doi: 10.1016/j.sapharm.2010.02.004.

20.

Effects of Medicare Part D coverage gap on medication adherence.

Zhang Y, Baik SH, Lave JR.

Am J Manag Care. 2013 Jun 1;19(6):e214-24.

Supplemental Content

Support Center